Skip to main content
SpringerLink
Log in

Alectinib

Transformation of lung adenocarcinoma to non-small cell lung cancer following alectinib resistance : case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Koyama K, et al. Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma. Pathology International 69: 294-299, No. 5, May 2019. Available from: URL: http://doi.org/10.1111/pin.12782 -Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib. Reactions Weekly 1765, 19 (2019). https://doi.org/10.1007/s40278-019-65776-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-65776-6

Search

Navigation